| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |